News – Page 17 – Alligator Bioscience

2021-11-10

Alligator Bioscience to Participate in Upcoming Investor Conferences

Lund, Sweden, November 10, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that Søren Bregenholt, Chief Executive Offi ...

2021-11-092022-07-20

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HO ...

2021-11-08

First Patient Dosed in Study Evaluating Mitazalimab in Combination with Cancer Vaccine for Patients with Pancreatic Cancer Lund, Sweden, N ...

2021-11-08

Today, on 8 November 2021, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the adopted resolutions follow ...

2021-11-03

Lund, Sweden, November 3, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the Nomination Committee in preparation ...

2021-10-22

The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or "the Company") has previously, subject to approval ...

2021-10-21

The press release as of October 21, 2021 regarding the Interim report January – September 2021 incorrectly contained a so-called MAR marking ...

2021-10-21

Regulatory

First Patient Dosed in Optimize-1 Phase II “We continued to make great strides in the third quarter of 2021. The first patient was dosed in ...

2021-10-21

Lund, Sweden, October 20, 2021 – Alligator Bioscience AB (“Alligator” or the “Company”) today announced that the Company was notified that t ...